ArticleCureus2024
Transdermal Ketoprofen Versus Fentanyl Patches for Pain Management Post-cesarean Section: A Comparative, Randomized, Double-Blind Study.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPostoperative pain management after a cesarean section is essential to promote mother-infant bonding and ease of breastfeeding. Transdermal patches present a viable alternative to oral medications, offering controlled drug delivery and better bioavailability while avoiding first-pass metabolism, all of which can facilitate smoother recovery and rehabilitation.
methodsThis comparative, randomized, double-blind study was conducted on 70 parturients scheduled for cesarean section under spinal anesthesia, classified as ASA II. Patients were randomly divided into two groups: Group K (transdermal ketoprofen patch, 30 mg) and Group F (transdermal fentanyl patch, 25 mcg). The patches were applied immediately after spinal anesthesia. Pain was assessed using the Visual Analogue Scale (VAS), and sedation was assessed using the Richmond Agitation-Sedation Scale for 24 hours.
resultsThere was no statistically significant difference in the VAS scores between the two groups from two to 14 hours postoperatively. However, a statistically significant difference was observed at 16 hours (Group K 2 ± 0.87 vs. Group F 2.5 ± 0.86, p = 0.029) and 20 hours (Group K 1.77 ± 0.86 vs. Group F 2.33 ± 0.8, p = 0.011). Rescue analgesia was required in seven (20%) of the patients in Group K and 12 (34.29%) of the patients in Group F, though this difference was not statistically significant. At 20 hours, Group K had more alert and calm patients (33 (94.29%) vs. 26 (74.29%)), with fewer drowsy or restless patients compared to Group F (p = 0.044). At 24 hours, Group K had significantly fewer drowsy patients (0 (0%) vs. 13 (37.14%)) and more alert patients (34 (97.14%) vs. 19 (54.29%)), with fewer restless patients (p < 0.0001).
conclusionBoth the ketoprofen patch (30 mg) and the fentanyl patch (25 mcg) provided comparable analgesia for the first 12 hours. However, at 16 and 20 hours, the ketoprofen patch was more effective than the fentanyl patch in providing analgesia. More patients in the fentanyl group were drowsy after 16 hours, though normal sleep patterns may have contributed to this observation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.